Tumor invasion by the penetration of cancer cells through the ECM and into neighboring tissue, requires combined effects of enhanced cell motility and alterations in the dynamics of focal adhesions, together with proteolytic degradation of the matrix [48, 49], e.g. by matrix metallopeptidases such as MMP9, shown to be increased in MSTO-CR cells. The gene discussed is MMP9; the disease is cancer.